JP6573286B2 - 感染の処置での使用のための治療剤 - Google Patents
感染の処置での使用のための治療剤 Download PDFInfo
- Publication number
- JP6573286B2 JP6573286B2 JP2017503081A JP2017503081A JP6573286B2 JP 6573286 B2 JP6573286 B2 JP 6573286B2 JP 2017503081 A JP2017503081 A JP 2017503081A JP 2017503081 A JP2017503081 A JP 2017503081A JP 6573286 B2 JP6573286 B2 JP 6573286B2
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- carrier
- donor
- acetyl
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1405874.7 | 2014-04-01 | ||
| GBGB1405874.7A GB201405874D0 (en) | 2014-04-01 | 2014-04-01 | A therapeutic agent for use in the treatment of infections |
| GBGB1415063.5A GB201415063D0 (en) | 2014-04-01 | 2014-08-26 | A therapeutic agent for use in the treatment of infections |
| GB1415063.5 | 2014-08-26 | ||
| PCT/GB2015/000100 WO2015150722A1 (en) | 2014-04-01 | 2015-03-24 | A therapeutic agent for use in the treatment of infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017510648A JP2017510648A (ja) | 2017-04-13 |
| JP2017510648A5 JP2017510648A5 (enExample) | 2019-06-20 |
| JP6573286B2 true JP6573286B2 (ja) | 2019-09-11 |
Family
ID=50737835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017503081A Active JP6573286B2 (ja) | 2014-04-01 | 2015-03-24 | 感染の処置での使用のための治療剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9913805B2 (enExample) |
| EP (2) | EP3125874B1 (enExample) |
| JP (1) | JP6573286B2 (enExample) |
| KR (2) | KR102359855B1 (enExample) |
| CN (1) | CN106456557B (enExample) |
| AU (1) | AU2015242495B2 (enExample) |
| CA (1) | CA2943431C (enExample) |
| DK (1) | DK3125874T3 (enExample) |
| ES (2) | ES2953755T3 (enExample) |
| GB (3) | GB201405874D0 (enExample) |
| IL (1) | IL247969B (enExample) |
| MX (1) | MX2016012757A (enExample) |
| NZ (1) | NZ724298A (enExample) |
| SG (2) | SG11201608093WA (enExample) |
| WO (1) | WO2015150722A1 (enExample) |
| ZA (1) | ZA201606387B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201405874D0 (en) * | 2014-04-01 | 2014-05-14 | Aga Nanotech Ltd | A therapeutic agent for use in the treatment of infections |
| CN107281220B (zh) * | 2016-03-31 | 2020-02-14 | 中国科学院上海硅酸盐研究所 | 一种介孔氧化硅基活性氧(ros)放疗增敏剂及其制备方法 |
| CN106860032B (zh) * | 2016-10-25 | 2021-04-09 | 咏达生医材料股份有限公司 | 一种气态皮肤供氧美白产品及其应用 |
| JP2019194162A (ja) * | 2018-05-01 | 2019-11-07 | ツァ ギャリー | 肌の酸素供給による美白及び加熱機能を備えた通気性材料 |
| JP7372706B2 (ja) | 2019-10-10 | 2023-11-01 | アルファ タウ メディカル リミテッド | 放射線治療源の湿式調製 |
| GB2592911B (en) * | 2020-02-28 | 2023-06-28 | Aga Nanotech Ltd | A plasma-activatable wound dressing for treatment of infections |
| GB202005556D0 (en) | 2020-04-16 | 2020-06-03 | Aga Nanotech Ltd | Covid face mask |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997007777A1 (en) * | 1995-08-15 | 1997-03-06 | Robert Eric Montgomery | Peroxidase-activating oral compositions |
| DE59912558D1 (de) * | 1999-07-02 | 2005-10-20 | Cognis Ip Man Gmbh | Mikrokapseln - IV |
| AU4477001A (en) * | 2000-04-18 | 2001-10-30 | Peptron Inc. | Injectable sustained release pharmaceutical composition and processes for preparing the same |
| KR100342746B1 (ko) * | 2000-06-27 | 2002-07-03 | 김찬화 | 인슐린의 방출제어제제 및 그 방법 |
| GB0411304D0 (en) * | 2004-05-21 | 2004-06-23 | Fellows Adrian N | An antimicrobial composition |
| US20060088498A1 (en) * | 2004-10-27 | 2006-04-27 | Truox, Inc. | Anti-microbial composition using in-situ generation of an oxidizing agent |
| EP1919507A2 (en) * | 2005-08-04 | 2008-05-14 | Thomas William Rademacher | Nanoparticles comprising antibacterial ligands |
| KR20070071225A (ko) * | 2005-12-29 | 2007-07-04 | 애경산업(주) | 치아 미백용 조성물 |
| GB0711952D0 (en) | 2007-06-20 | 2007-08-01 | King S College London | Microspheres |
| WO2009108407A1 (en) * | 2008-02-25 | 2009-09-03 | The University Of North Carolina At Charlotte Office Of Technology Transfer | Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| CA2730995C (en) * | 2008-07-17 | 2016-11-22 | Micell Technologies, Inc. | Drug delivery medical device |
| US8969282B2 (en) * | 2009-02-05 | 2015-03-03 | American Sterilizer Company | Low odor, hard surface sporicide |
| KR101136028B1 (ko) * | 2009-04-27 | 2012-04-18 | 한양대학교 산학협력단 | 다공성 마이크로스피어의 제조방법 |
| US8889161B2 (en) * | 2009-04-27 | 2014-11-18 | Premier Dental Products Company | Microencapsulated compositions and methods for tissue mineralization |
| NZ600269A (en) * | 2009-05-20 | 2014-02-28 | Dec Int Nz Ltd | Delivery device for treatment of mastitis |
| US9187594B2 (en) * | 2010-02-09 | 2015-11-17 | The Regents Of The University Of Michigan | Nano-fibrous microspheres and methods for making the same |
| HUE033386T2 (en) * | 2010-07-09 | 2017-11-28 | Innocore Tech B V | Release of Biodegradable Phase Separated Segmented Multiblock Copolymers and Biologically Active Polypeptides |
| EP2611466B1 (en) * | 2010-08-30 | 2019-06-12 | President and Fellows of Harvard College | Shear controlled release of thrombolytic therapies for stenotic lesions |
| GB201405874D0 (en) * | 2014-04-01 | 2014-05-14 | Aga Nanotech Ltd | A therapeutic agent for use in the treatment of infections |
-
2014
- 2014-04-01 GB GBGB1405874.7A patent/GB201405874D0/en not_active Ceased
- 2014-08-26 GB GBGB1415063.5A patent/GB201415063D0/en not_active Ceased
-
2015
- 2015-03-24 KR KR1020167030614A patent/KR102359855B1/ko active Active
- 2015-03-24 CA CA2943431A patent/CA2943431C/en active Active
- 2015-03-24 AU AU2015242495A patent/AU2015242495B2/en active Active
- 2015-03-24 EP EP15714598.8A patent/EP3125874B1/en active Active
- 2015-03-24 DK DK15714598.8T patent/DK3125874T3/da active
- 2015-03-24 US US15/126,511 patent/US9913805B2/en active Active
- 2015-03-24 MX MX2016012757A patent/MX2016012757A/es active IP Right Grant
- 2015-03-24 SG SG11201608093WA patent/SG11201608093WA/en unknown
- 2015-03-24 CN CN201580018976.4A patent/CN106456557B/zh active Active
- 2015-03-24 ES ES20215977T patent/ES2953755T3/es active Active
- 2015-03-24 KR KR1020227003691A patent/KR102482597B1/ko active Active
- 2015-03-24 SG SG10201801524PA patent/SG10201801524PA/en unknown
- 2015-03-24 ES ES15714598T patent/ES2855985T3/es active Active
- 2015-03-24 JP JP2017503081A patent/JP6573286B2/ja active Active
- 2015-03-24 EP EP20215977.8A patent/EP3848022B1/en active Active
- 2015-03-24 WO PCT/GB2015/000100 patent/WO2015150722A1/en not_active Ceased
- 2015-03-24 GB GB1617053.2A patent/GB2538923B/en active Active
- 2015-03-24 NZ NZ724298A patent/NZ724298A/en not_active IP Right Cessation
-
2016
- 2016-09-15 ZA ZA2016/06387A patent/ZA201606387B/en unknown
- 2016-09-22 IL IL247969A patent/IL247969B/en active IP Right Grant
-
2018
- 2018-01-18 US US15/874,552 patent/US10933026B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6573286B2 (ja) | 感染の処置での使用のための治療剤 | |
| Li et al. | Nano–bio interactions: biofilm‐targeted antibacterial nanomaterials | |
| Li et al. | Antimicrobial hydrogels: potential materials for medical application | |
| AU2015315108B2 (en) | Antimicrobial and biologically active polymer composites and related methods, materials and devices | |
| Quijia et al. | Metal-organic frameworks for diagnosis and therapy of infectious diseases | |
| Xue et al. | An exceptional broad-spectrum nanobiocide for multimodal and synergistic inactivation of drug-resistant bacteria | |
| Shende et al. | Polymeric nanodroplets: an emerging trend in gaseous delivery system | |
| Wu et al. | New Advances in Periodontal Functional Materials Based on Antibacterial, Anti‐Inflammatory, and Tissue Regeneration Strategies | |
| JP2017510648A5 (enExample) | ||
| Kanth et al. | Recent advancements and perspective of ciprofloxacin-based antimicrobial polymers | |
| HK40052395A (en) | A therapeutic agent for use in the treatment of infections | |
| CN213687182U (zh) | 一种空气净化装置 | |
| HK1233167B (zh) | 在感染的治疗中使用的治疗剂 | |
| HK1233167A1 (en) | A therapeutic agent for use in the treatment of infections | |
| US20190060270A1 (en) | Disinfectant agent | |
| Zewdu et al. | Emerging mesoporous silica nanoparticle-mediated controlled and targeted drug delivery system: Present status and future prospects | |
| JP2023516026A (ja) | 活性化可能な創傷被覆材 | |
| Alam et al. | Nanotechnology: A Recent Breakthrough Against Resistant Biofilm Infection | |
| TW202415819A (zh) | 抗菌性纖維的結構及其製造方法 | |
| JP2009184973A (ja) | カーボンナノホーンをキャリアとする抗菌剤徐放化製剤 | |
| CN116617257A (zh) | 碳基材料抑菌剂、其应用、抗菌组合物及抗菌药物 | |
| Stewart | Co-Assembled Drug-Silica Materials for Antimicrobial and Antidegradative Dental Applications | |
| CN108697080A (zh) | 消毒剂 | |
| BR112012007111B1 (pt) | Composição microbicida para revestimento de um dispositivo médico, dispositivo médico e método para fabricação de um revestimento para um dispositivo médico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161201 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180216 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181018 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181019 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190117 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190228 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20190516 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190709 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190807 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6573286 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |